Last reviewed · How we verify
Astaxanthine
At a glance
| Generic name | Astaxanthine |
|---|---|
| Also known as | Astaxanthine 8mg |
| Sponsor | Indonesia University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
- Sinusitis
Key clinical trials
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Dietary Supplement for Myopia Control (NA)
- Haematococcus Pluvialis Astaxanthin for Brain Aging (NA)
- Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin (NA)
- ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments (PHASE2)
- Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation (NA)
- Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects (NA)
- Astaxanthin for Management of Inflammation in Knee Osteoarthritis (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Astaxanthine CI brief — competitive landscape report
- Astaxanthine updates RSS · CI watch RSS
- Indonesia University portfolio CI